mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |